Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia

National Center for Complementary and Integrative Health (NCCIH)40 enrolled

Overview

The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.

As per Brief Summary

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Fibromyalgia

Interventions

Intravenous micronutrient therapyDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion criteria: * Meet the American College of Rheumatology criteria for Fibromyalgia diagnosis; * On no medication for Fibromyalgia other than acetaminophen, or willing to stop all such medication for the duration of the study * Willing to stop all FMS medication for the duration of the study or be on a stable dose of such medication for at least 3 months Exclusion criteria: * Other concurrent medical conditions such as rheumatologic disease, chronic infection, untreated endocrine disorders, unstable seizures, psychiatric disorders, acute peptic ulcer disease, congestive heart failure, chronic liver disorders and/or bleeding problems * Allergy to thiamin * Unwilling to stop vitamin supplementation for the duration of the study * PLEASE NOTE: Travel to and accomodations at the study site can NOT be compensated. Anyone wishing to travel from outside of the study site's geographic area must do so at their own risk and expense.

Locations (1)

Yale-Griffin Prevention Research Center

Derby, Connecticut, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.